Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/03/2012WO2012055863A1 Covalent cellulosomes and uses thereof
05/03/2012WO2012055798A1 Increasing nadph availability for methionine production
05/03/2012WO2012055573A1 Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
05/03/2012WO2012055362A1 Hbv treatment
05/03/2012WO2012055083A1 Fusion protein comprising vegi, pharmaceutical composition and use thereof
05/03/2012WO2012055073A1 Method for setting temperature of polymerase chain reaction and instrument thereof
05/03/2012WO2012055069A1 Luminophore-labeled molecules coupled with particles for microarray-based assays
05/03/2012WO2012055030A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012WO2012054975A1 Method of microvesicle enrichment
05/03/2012WO2012031109A3 Methods and compositions for engineering recombinant dna molecules
05/03/2012WO2012030068A3 Polypeptide associated with the synthesis of 1-deoxynojirimycin, and a use therefor
05/03/2012WO2012027558A3 OPTIMIZED miRNA CONSTRUCTS
05/03/2012WO2012025895A3 Recombinant therapeutic glycine n-acyltransferase
05/03/2012WO2012020965A3 Pik3ca mutation detection method and kit using real-time pcr clamping of pna
05/03/2012WO2012018610A3 Transgenic animals and methods of use
05/03/2012WO2012017256A3 Scaffold peptides
05/03/2012WO2012008746A3 Dna double helical structure model
05/03/2012WO2012006437A3 Polypeptides having antiviral activity and methods for use thereof
05/03/2012WO2012005529A3 Transgenic mice expressing human ferritin in a manner non-specific to tissue, and use thereof
05/03/2012WO2012002762A3 Peptide for the treatment or prevention of allergic diseases
05/03/2012WO2011156430A3 Generation and expression of engineered i-onui endonuclease and its homologues and uses thereof
05/03/2012WO2011150320A3 Activators of innate immunity
05/03/2012WO2011133952A3 New bacterium for production of chemicals and recombinants thereof
05/03/2012WO2011041847A8 Chaperonin 10 variants
05/03/2012US20120110703 Protein having novel prenyltransferase activity and gene encoding the same
05/03/2012US20120110700 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof
05/03/2012US20120110699 Method for promoting the formation of secondary cell wall of plant
05/03/2012US20120110698 Expression of Transcription Regulators that Provide Heat Tolerance
05/03/2012US20120110697 Method of constructing novel higher plant and method of promoting the growth of higher plant
05/03/2012US20120110695 Plant yield improvement by ste20-like gene expression
05/03/2012US20120110694 Plant myb transcription factor homologs
05/03/2012US20120110693 Targeting nucleic acids in mitochondria
05/03/2012US20120110688 Aad-12 event 1606 and related transgenic soybean lines
05/03/2012US20120110687 Pepper hybrid ps 16351609
05/03/2012US20120110686 Cand45 tRNA-Derived Expression System for Gene Modulation
05/03/2012US20120110685 Modular dna-binding domains and methods of use
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108804 Compositions and methods for preparing short rna molecules and other nucleic acids
05/03/2012US20120108795 Antibodies Binding Human Collagen II
05/03/2012US20120108790 Truncated Somatostatin Receptors
05/03/2012US20120108662 Compositions and methods for treating skin disorders
05/03/2012US20120108657 Disease-associated protein
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108653 Oligomers
05/03/2012US20120108652 Oligomers
05/03/2012US20120108646 RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof
05/03/2012US20120108523 Disease-associated protein
05/03/2012US20120108521 Immunostimulatory compositions and uses thereof
05/03/2012US20120108497 Compositions for conferring tolerance to viral disease in social insects, and the use thereof
05/03/2012US20120108493 Polypeptide Fragments Comprising Endonuclease Activity and Their Use
05/03/2012US20120108464 Test systems, methods and uses involving as160 protein
05/03/2012US20120107939 Down-regulation of gene expression using artificial micrornas
05/03/2012US20120107938 Methods and kits for high efficiency engineering of conditional mouse alleles
05/03/2012US20120107937 Mitochondrial enhancement of cells
05/03/2012US20120107929 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids, and Uses Thereof
05/03/2012US20120107928 Antibody Inhibitors of GDF-8 and Uses Thereof
05/03/2012US20120107923 Expression vectors which inhibit synthesis of catalase and uses thereof
05/03/2012US20120107907 Thermostable neutral metalloproteases
05/03/2012US20120107906 Novel lipolytic enzyme lip1
05/03/2012US20120107905 Variants of Fungal Serine Protease
05/03/2012US20120107904 Carboxy terminal residues as predictors and regulators of protein stability
05/03/2012US20120107903 Mutant Glucose Dehydrogenase
05/03/2012US20120107899 Heat-Stable Carbonic Anhydrases and Their Use
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107889 Endophytic yeast strains, methods for ethanol and xylitol production, methods for biological nitrogen fixation, and a genetic source for improvement of industrial strains
05/03/2012US20120107882 Recombinant Microorganism And Method For Producing L-Lysine
05/03/2012US20120107879 Methods for production and purification of nucleic acid molecules
05/03/2012US20120107876 Novel fusion tag offering solubility to insoluble recombinant protein
05/03/2012US20120107875 Expression Cassette, Recombinant Host Cell and Process for Producing a Target Protein
05/03/2012US20120107873 Method of Producing a Sweet Protein
05/03/2012US20120107856 New Fungal Production System
05/03/2012US20120107852 Method for preparing modified polypeptides
05/03/2012US20120107833 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107812 Means and methods for investigating nucleic acid sequences
05/03/2012US20120107807 Highly sensitive method for the detection of cytosine methylation patterns
05/03/2012US20120107801 High-efficiency homologous recombination in the oil-producing alga, nannochloropsis
05/03/2012US20120107390 Feline infectious peritonitis vaccine
05/03/2012US20120107364 Antibody having anti-cancer activity
05/03/2012US20120107362 Neurotoxins exhibiting shortened biological activity
05/03/2012US20120107360 Gamma-glutamyl transpeptidase attenuated francisella
05/03/2012US20120107358 Subgenomic replicons of the flavivirus dengue
05/03/2012US20120107357 Novel divergent picornavirus: cosavirus
05/03/2012US20120107350 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
05/03/2012US20120107343 Production of recombinant proteins in ciliates and uses thereof
05/03/2012US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
05/03/2012US20120107339 Chimeric Factor H Binding Proteins (fHBP) Containing a Heterologous B Domain and Methods of Use
05/03/2012US20120107338 Identification of a novel retrovirus in patients with benign prostatic hyperplasia
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107330 Antagonists, uses & methods for partially inhibiting tnfr1
05/03/2012US20120107325 IL-17 Antagonistic Antibodies
05/03/2012US20120107324 TARGETED BINDING AGENTS DIRECTED TO a5ß1 AND USES THEREOF
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
05/03/2012US20120107318 Methods of administering pif agonist peptides and uses thereof
05/03/2012US20120107313 Mammalian receptor proteins; related reagents and methods
05/03/2012US20120107299 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
05/03/2012US20120107285 Mitochondrial enhancement of cells
05/03/2012US20120107267 Interleukin-21 variants having antagonistic binding to the il-21 receptor
05/03/2012US20120107265 Method for producing monoterpene and monoterpinoid compounds and use thereof
05/03/2012US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines
1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 4023